Rapamycin and Interleukin-10 Treatment Induces T Regulatory Type 1 Cells That Mediate Antigen-Specific Transplantation Tolerance
Manuela Battaglia(Vita-Salute San Raffaele University), Maria‐Grazia Roncarolo(Vita-Salute San Raffaele University), Cristina Mocchetti(The San Raffaele Telethon Institute for Gene Therapy), Angela Stabilini(The San Raffaele Telethon Institute for Gene Therapy), Elena Draghici(The San Raffaele Telethon Institute for Gene Therapy), Silvia Gregori(The San Raffaele Telethon Institute for Gene Therapy), Ezio Bonifacio(Technische Universität Dresden)
Cited by 170
Related Papers
Gene Therapy for Immunodeficiency Due to Adenosine Deaminase Deficiency
|New England Journal of Medicine|2009|1k
The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM
|Nature|1998|942
Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells.
|The Journal of Experimental Medicine|1996|774
Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI.
|Proceedings of the National Academy of Sciences|1991|752
Rapamycin Promotes Expansion of Functional CD4+CD25+FOXP3+ Regulatory T Cells of Both Healthy Subjects and Type 1 Diabetic Patients
|The Journal of Immunology|2006|726